 | Up a level |
Journal Article
Blohmer, Jens-Uwe, Link, Theresa, Reinisch, Mattea, Just, Marianne, Untch, Michael, Stotzer, Oliver, Fasching, Peter A., Schneeweiss, Andreas, Wimberger, Pauline, Seiler, Sabine, Huober, Jens, Thill, Marc, Jackisch, Christian, Rhiem, Kerstin, Solbach, Christine, Hanusch, Claus, Seither, Fenja, Denkert, Carsten, Engels, Knut, Nekljudova, Valentina and Loibl, Sibylle (2022). Effect of Denosumab Added to 2 Different nab-Paclitaxel Regimens as Neoadjuvant Therapy in Patients With Primary Breast Cancer The GeparX 2 x 2 Randomized Clinical Trial. JAMA Oncol., 8 (7). S. 1010 - 1019. CHICAGO: AMER MEDICAL ASSOC. ISSN 2374-2445
Denkert, Carsten, Seither, Fenja, Schneeweiss, Andreas, Link, Theresa, Blohmer, Jens-Uwe, Just, Marianne, Wimberger, Pauline, Forberger, Almuth, Tesch, Hans, Jackisch, Christian, Schmatloch, Sabine, Reinisch, Mattea, Solomayer, Erich F., Schmitt, Wolfgang D., Hanusch, Claus, Fasching, Peter A., Luebbe, Kristina, Solbach, Christine, Huober, Jens, Rhiem, Kerstin, Marme, Frederik, Reimer, Toralf, Schmidt, Marcus 
ORCID: 0000-0003-1365-2414, Sinn, Bruno, V, Janni, Wolfgang, Stickeler, Elmar, Michel, Laura, Stoetzer, Oliver, Hahnen, Eric, Furlanetto, Jenny, Seiler, Sabine, Nekljudova, Valentina, Untch, Michael and Loibl, Sibylle
(2021).
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials.
Lancet Oncol., 22 (8).
S. 1151 - 1162.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488
Furlanetto, Jenny, Moebus, Volker, Schneeweiss, Andreas, Rhiem, Kerstin, Tesch, Hans, Blohmer, Jens-Uwe ORCID: 0000-0002-7969-250X, Luebbe, Kristina, Untch, Michael, Salat, Christoph, Huober, Jens, Klare, Peter, Schmutzler, Rita, Couch, Fergus J., Lederer, Bianca, Gerber, Bernd, Zahm, Dirk-Michael, Bauerfeind, Ingo, Nekljudova, Valentina, Hanusch, Claus, Jackisch, Christian, Link, Theresa, Hahnen, Eric, Loibl, Sibylle and Fasching, Peter A.
(2021).
Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy.
Eur. J. Cancer, 145.
S. 44 - 53.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1879-0852
Gerber, Bernd, Schneeweiss, Andreas, Moebus, Volker, Golatta, Michael ORCID: 0000-0002-2605-0060, Tesch, Hans, Krug, David ORCID: 0000-0001-8811-5416, Hanusch, Claus, Denkert, Carsten, Luebbe, Kristina, Heil, Joerg, Huober, Jens, Ataseven, Beyhan ORCID: 0000-0002-2823-7590, Klare, Peter, Hahn, Markus, Untch, Michael, Kast, Karin, Jackisch, Christian, Thomalla, Joerg, Seither, Fenja, Blohmer, Jens-Uwe ORCID: 0000-0002-7969-250X, Rhiem, Kerstin, Fasching, Peter A., Nekljudova, Valentina, Loibl, Sibylle and Kuehn, Thorsten ORCID: 0000-0002-8708-2824
(2022).
Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the GeparOcto Trial.
Cancers, 14 (3).
BASEL:
MDPI.
ISSN 2072-6694
Marme, Frederik, Solbach, Christine, Michel, Laura, Schneeweiss, Andreas, Blohmer, Jens-Uwe ORCID: 0000-0002-7969-250X, Huober, Jens, Fasching, Peter A., Jackisch, Christian, Nekljudova, Valentina, Link, Theresa, Rhiem, Kerstin, Rey, Julia, Denkert, Carsten, Hanusch, Claus, Tesch, Hans, Lederer, Bianca, Loibl, Sibylle and Untch, Michael
(2021).
Utility of the CPS plus EG scoring system in triple-negative breast cancer treated with neoadjuvant chemotherapy.
Eur. J. Cancer, 153.
S. 203 - 213.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1879-0852
Schneeweiss, Andreas, Michel, Laura L., Moebus, Volker, Tesch, Hans, Klare, Peter, Hahnen, Eric, Denkert, Carsten, Kast, Karin, Pohl-Rescigno, Esther, Hanusch, Claus, Link, Theresa, Untch, Michael, Jackisch, Christian, Blohmer, Jens-Uwe ORCID: 0000-0002-7969-250X, Fasching, Peter A., Solbach, Christine, Schmutzler, Rita K., Huober, Jens, Rhiem, Kerstin, Nekljudova, Valentina, Luebbe, Kristina and Loibl, Sibylle
(2022).
Survival analysis of the randomised phase III GeparOcto trial comparing neoadjuvant chemotherapy of intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for patients with high-risk early breast cancer.
Eur. J. Cancer, 160.
S. 100 - 112.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1879-0852
von Minckwitz, Gunter, Schweller, Kathrin, Schmidt, Marcus ORCID: 0000-0003-1365-2414, Barinoff, Jana, Mundhenke, Christoph ORCID: 0000-0002-6989-6250, Cufer, Tanja, Maartense, Eduard ORCID: 0000-0002-5891-031X, de Jongh, Felix E., Baumann, Klaus H., Bischoff, Joachim, Harbeck, Nadia, Lueck, Hans-Joachim, Maass, Nicolai, Zielinski, Christoph, Andersson, Michael, Stein, Robert C., Nekljudova, Valentina and Loibl, Sibylle
(2011).
Trastuzumab beyond progression: Overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer.
Eur. J. Cancer, 47 (15).
S. 2273 - 2282.
OXFORD:
ELSEVIER SCI LTD.
ISSN 0959-8049